Posts

HHS Issues Guidance to Shield Pharma from Anti-Kickback Violations in TrumpRx Direct-to-Consumer Drug Sales

on

Lilly Slightly Lowers Self-Pay Prices for Single-Dose Vials of Zepbound

on

More Than a Third of New Zepbound Prescriptions Driven by Lilly’s DTC Program

on

More Than a Third of New Zepbound Prescriptions Driven by Lilly’s DTC Program

on

Trump Administration and Pfizer Strike 'Most Favored Nation' Drug Price Deal

on

Novartis and Boehringer Ingelheim Launch Direct-to-Consumer Drug Sales, Bypassing Middlemen

on

FDA Crackdown on Pharma TV Ads Targets Pfizer, Novartis, BMS, Lilly & Others

on

Battle Intensifies in the Obesity Drug Market as Novo Nordisk and Eli Lilly Vie for Dominance

on

Pfizer CEO Holds 'Extremely Productive' Talks With Trump Administration Amid MFN Pricing and Tariff Threats

on

DTC vs. DTP: Regulatory Uncertainty & Access Challenges Drive New Go-to-Market Models (2025 Update)

on

Bristol Myers Squibb and Pfizer Launch Direct-to-Consumer Discount Program for Eliquis

on